Viyash Scientific has announced that its Board of Directors will convene on February 05, 2026, to review and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ending December 31, 2025. The trading window for dealing in the company’s securities has been closed from January 01, 2026, and will reopen 48 hours after the results are announced, expected by February 07, 2026.
Board Meeting Scheduled
A meeting of the Board of Directors at Viyash Scientific is scheduled for February 05, 2026. During this meeting, the board will consider and approve the Unaudited Standalone and Consolidated Financial Results.
Financial Results on the Agenda
The primary agenda is the approval of the financial results for the third quarter (Q3) and nine months ending December 31, 2025. These results will provide insights into the company’s performance during this period.
Trading Window Closure
In accordance with the company’s code of conduct, the trading window for dealing in the securities of Viyash Scientific has been closed since January 01, 2026. This closure impacts designated persons and their immediate relatives. The window will remain closed until 48 hours after the announcement of the financial results, which is expected to be by February 07, 2026.
Source: BSE
